MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 13, 2021

Total Value ($000): $608,714 (100.0% shares, 0.0% debt)

Holdings (14)

CGEM Cullinan Management, Inc. 33.5%

Value ($000) $203,783 Shares 7,913,887 Est. Cost $40.60 Unrealized -24.2%

— iTeos Therapeutics, Inc. 9.9%

Value ($000) $59,985 Shares 2,338,581 Est. Cost $24.67 Unrealized —

— TCR2 Therapeutics, Inc. 9.1%

Value ($000) $55,318 Shares 3,370,982 Est. Cost $14.28 Unrealized —

— Repare Therapeutics, Inc. 8.6%

Value ($000) $52,260 Shares 1,676,087 Est. Cost $31.02 Unrealized —

— Harpoon Therapeutics, Inc. 7.3%

Value ($000) $44,338 Shares 3,196,707 Est. Cost $14.79 Unrealized —

HOWL Werewolf Therapeutics, Inc. 6.8%

Value ($000) $41,647 Shares 2,388,011 Est. Cost $13.70 Unrealized 0.0%

— Oncorus, Inc. 5.4%

Value ($000) $32,803 Shares 2,377,031 Est. Cost $32.33 Unrealized —

— MEI Pharma, Inc. 4.7%

Value ($000) $28,893 Shares 10,137,859 Est. Cost $3.11 Unrealized —

— Turning Point Therapeutics, Inc. 3.5%

Value ($000) $21,002 Shares 269,186 Est. Cost $44.66 Unrealized —

— Epizyme, Inc. 3.2%

Value ($000) $19,375 Shares 2,331,534 Est. Cost $22.28 Unrealized —

— G1 Therapeutics, Inc. 2.9%

Value ($000) $17,833 Shares 812,794 Est. Cost $26.43 Unrealized —

— Merus N.V. 2.4%

Value ($000) $14,768 Shares 700,879 Est. Cost $16.09 Unrealized —

— YmAbs Therapeutics, Inc. 1.9%

Value ($000) $11,400 Shares 337,291 Est. Cost $31.25 Unrealized —

ADCT ADC Therapeutics, Inc. 0.9%

Value ($000) $5,309 Shares 218,027 Est. Cost $38.22 Unrealized -39.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Management, Inc.	7,913,887	$203,783	33.5%	$40.60	-24.2%	Common	230031106
—	iTeos Therapeutics, Inc.	2,338,581	$59,985	9.9%	$24.67	—	Common	46565G104
—	TCR2 Therapeutics, Inc.	3,370,982	$55,318	9.1%	$14.28	—	Common	87808K106
—	Repare Therapeutics, Inc.	1,676,087	$52,260	8.6%	$31.02	—	Common	760273102
—	Harpoon Therapeutics, Inc.	3,196,707	$44,338	7.3%	$14.79	—	Common	41358P106
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$41,647	6.8%	$13.70	0.0%	Common	95075A107
—	Oncorus, Inc.	2,377,031	$32,803	5.4%	$32.33	—	Common	68236R103
—	MEI Pharma, Inc.	10,137,859	$28,893	4.7%	$3.11	—	Common	552798202
—	Turning Point Therapeutics, Inc.	269,186	$21,002	3.5%	$44.66	—	Common	90041T108
—	Epizyme, Inc.	2,331,534	$19,375	3.2%	$22.28	—	Common	29428V104
—	G1 Therapeutics, Inc.	812,794	$17,833	2.9%	$26.43	—	Common	3621LQ109
—	Merus N.V.	700,879	$14,768	2.4%	$16.09	—	Common	N5749R100
—	YmAbs Therapeutics, Inc.	337,291	$11,400	1.9%	$31.25	—	Common	984241109
ADCT	ADC Therapeutics, Inc.	218,027	$5,309	0.9%	$38.22	-39.3%	Common	H0036K147